Why the study?
Does bisoprolol 20 mg once daily reduce blood pressure without reducing ejection fraction in patients with mild-to-moderate essential hypertension?
Does bisoprolol 20 mg once daily reduce blood pressure without reducing ejection fraction in patients with mild-to-moderate essential hypertension?
Bisoprolol 20 mg daily effectively lowers blood pressure and heart rate in mild-to-moderate hypertension without compromising left ventricular ejection fraction.
Answers are grounded in this paper and cite their sources.
Supports once-daily bisoprolol 20 mg in mild hypertension; extends RCT evidence for LVEF preservation.
Twenty-six patients with mild-to-moderate essential hypertension participated in a 6-week outpatient, multicenter, randomized, double-blind, placebo-controlled two-way crossover study to assess the hemodynamic effects of bisoprolol (20 mg QD) at steady state. Hemodynamic assessments included sitting blood pressure, heart rate, and left-ventricular ejection fraction by radionuclide ventriculography after 7 days of bisoprolol or placebo at trough (24 h post-dose) and peak (3 h post-dose) values. The group adjusted mean ejection fraction was not significantly different in patients receiving bisoprolol compared with the placebo group at either peak or trough measurements; in fact, means in patients taking bisoprolol were slightly higher than in the placebo group. No symptomatic hypotension was documented. Blood pressure, measured 24 hours after dosing, was significantly lower in those receiving bisoprolol when compared with the placebo group, by 7.7 mm Hg and 9 mm Hg for diastolic and systolic blood pressure, respectively. Similarly, mean values of heart rate were 10 beats/min lower in the bisoprolol patients than in the placebo group. Only headache and insomnia occurred as adverse events. Bisoprolol (20 mg QD) effectively lowered blood pressure over a 24-hour period without significantly reducing ejection fraction or causing adverse clinical or biochemical events.
No takes yet. Share an insight, caveat, or question.
Prisant et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: